Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

1.790 +0.090 (+5.29%)
Official Closing Price Updated: 8:00 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 75,217
Open 1.700
Bid (Size) 1.780 (100)
Ask (Size) 1.790 (200)
Prev. Close 1.700
Today's Range 1.700 - 1.790
52wk Range 0.8900 - 10.83
Shares Outstanding 8,457,967
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Reports Fiscal Third Quarter 2026 Results
From CEL-SCI Corporation
Via Business Wire

Performance

YTD
-65.2%
-65.2%
1 Month
+10.5%
+10.5%
3 Month
+72.1%
+72.1%
6 Month
-44.2%
-44.2%
1 Year
-79.7%
-79.7%

More News

Read More
News headline image
CEL-SCI Study Published in Peer-Reviewed Oral Oncology Supports Multikine's Biomarker Strategy and Potential Overall Survival Benefit Ahead of Head and Neck Cancer Confirmatory Registration Study
From CEL-SCI Corporation
Via Business Wire
Why DID CVM Shares Rally Over 7% Today? ↗
Via Stocktwits
Retail Buzz Builds Around Cel-Sci Stock Ahead Of Saudi Ruling On Cancer Drug Multikine ↗
Via Stocktwits
News headline image
Leading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation in Cancer Care
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Announces Closing of Offering
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Corporation Announces Pricing of Offering
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia
From CEL-SCI Corporation
Via Business Wire
InvestorNewsBreaks – CEL-SCI Corporation (NYSE American: CVM) Closes $7.2 Million Public Offering
Via Investor Brand Network
News headline image
CEL-SCI Reports Fiscal Second Quarter 2026 Results
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Announces Closing of Public Offering
From CEL-SCI Corporation
Via Business Wire
Tuesday's session: top gainers and losers ↗
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
Via Chartmill
News headline image
CEL-SCI Corporation Announces Pricing of Public Offering
From CEL-SCI Corporation
Via Business Wire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Reports Fiscal First Quarter 2026 Results
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Reports Fiscal 2025 Results
From CEL-SCI Corporation
Via Business Wire
News headline image
CEL-SCI Announces Closing of $10 Million Public Offering
From CEL-SCI Corporation
Via Business Wire
News headline image
Thursday's session: top gainers and losers ↗
Via Chartmill

Frequently Asked Questions

Is Cel-Sci Corporation Common Stock publicly traded?
Yes, Cel-Sci Corporation Common Stock is publicly traded.
What exchange does Cel-Sci Corporation Common Stock trade on?
Cel-Sci Corporation Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Cel-Sci Corporation Common Stock?
The ticker symbol for Cel-Sci Corporation Common Stock is CVM on the New York Stock Exchange
What is the current price of Cel-Sci Corporation Common Stock?
The current price of Cel-Sci Corporation Common Stock is 1.790
When was Cel-Sci Corporation Common Stock last traded?
The last trade of Cel-Sci Corporation Common Stock was at 09/29/26 08:00 PM ET
What is the market capitalization of Cel-Sci Corporation Common Stock?
The market capitalization of Cel-Sci Corporation Common Stock is 15.14M
How many shares of Cel-Sci Corporation Common Stock are outstanding?
Cel-Sci Corporation Common Stock has 15M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.